Sponsor Pipeline

Jiangsu Aosaikang Pharmaceutical Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
2
Recruiting
2
Phase 3
1
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-12 NCT07759934 ASK0912 Versus Polymyxin B for Injection in Adults With Hospital-Acquired or… Phase 2 Recruiting
2026-08-03 NCT07742852 ASKC200 for Knee Osteoarthritis Pain Phase 2 Active, Not Recruiting
2026-07-31 NCT07739368 Safety and Efficacy Study of Ferric Maltol To Treat Iron Deficiency Anaemia in Chinese… Phase 3 Completed
Active Trials by Phase
Phase 3
2
Phase 2
2
Phase 1/2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT04143607 ASK120067 Versus Gefitinib as First-line Treatment for EGFRm Locally Advanced or… Locally Advanced or Metastatic NSCLC Active, Not Recruiting
NCT07109531 ASKC202 Combined With Limertinib Versus Platinum-based Chemotherapy in Treatment of… Locally Advanced or Metastatic NSCLC Not Yet Recruiting
Phase 2
NCT07759934 ASK0912 Versus Polymyxin B for Injection in Adults With Hospital-Acquired or… Ventilator-associated Bacterial Pneumonia (VABP) Recruiting
NCT07742852 ASKC200 for Knee Osteoarthritis Pain Osteoarthritis (OA) of the Knee Active, Not Recruiting
Phase 1/2
NCT04632108 A 1/2 Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor… Malignant Solid Tumor Active, Not Recruiting
Phase 1
NCT05306132 Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor… Advanced Solid Tumor Recruiting
NCT06614608 The Safety and Pharmacokinetics of ASKC200 in Osteoarthritic Knee Pain Osteoarthritis, Knee Not Yet Recruiting
Disease Areas
Get alerts when Jiangsu Aosaikang Pharmaceutical Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free